Umbral Energy Corp Share Price Canadian Securities Exchange
Equities
CA90420Y1088
Pharmaceuticals
Sales 2022 | 29.57 40.45 2.46K | Sales 2023 | 29.79 40.76 2.48K | Capitalization | 14.15M 19.35M 1.18B |
---|---|---|---|---|---|
Net income 2022 | -24M -32.84M -2B | Net income 2023 | -20M -27.36M -1.67B | EV / Sales 2022 | 14,74,984 x |
Net Debt 2022 | 11.54M 15.79M 962M | Net Debt 2023 | 4.53M 6.2M 378M | EV / Sales 2023 | 6,26,876 x |
P/E ratio 2022 |
-1.26
x | P/E ratio 2023 |
-0.7
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 85.98% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | - | |
Jasmine Paige
DFI | Director of Finance/CFO | - | 14/23/14 |
Clinton Sharples
CHM | Chairman | - | 29/13/29 |
Members of the board | Title | Age | Since |
---|---|---|---|
Clinton Sharples
CHM | Chairman | - | 29/13/29 |
Céline Arsenault
BRD | Director/Board Member | - | 08/19/08 |
Chief Executive Officer | - | - |
1st Jan change | Capi. | |
---|---|---|
+39.33% | 6.11B | |
-18.38% | 4.35B | |
-9.17% | 3.18B | |
+3.98% | 3.15B | |
-3.41% | 2.51B | |
+48.74% | 1.98B | |
-4.82% | 1.74B | |
-1.24% | 1.63B | |
-8.96% | 1.6B |